121 related articles for article (PubMed ID: 26660343)
1. Tissue-Specific Differences in DNA Modifications (5-Hydroxymethylcytosine, 5-Formylcytosine, 5-Carboxylcytosine and 5-Hydroxymethyluracil) and Their Interrelationships.
Gackowski D; Zarakowska E; Starczak M; Modrzejewska M; Olinski R
PLoS One; 2015; 10(12):e0144859. PubMed ID: 26660343
[TBL] [Abstract][Full Text] [Related]
2. 5-Formylcytosine can be a stable DNA modification in mammals.
Bachman M; Uribe-Lewis S; Yang X; Burgess HE; Iurlaro M; Reik W; Murrell A; Balasubramanian S
Nat Chem Biol; 2015 Aug; 11(8):555-7. PubMed ID: 26098680
[TBL] [Abstract][Full Text] [Related]
3. Accurate quantification of 5-Methylcytosine, 5-Hydroxymethylcytosine, 5-Formylcytosine, and 5-Carboxylcytosine in genomic DNA from breast cancer by chemical derivatization coupled with ultra performance liquid chromatography- electrospray quadrupole time of flight mass spectrometry analysis.
Guo M; Li X; Zhang L; Liu D; Du W; Yin D; Lyu N; Zhao G; Guo C; Tang D
Oncotarget; 2017 Oct; 8(53):91248-91257. PubMed ID: 29207640
[TBL] [Abstract][Full Text] [Related]
4. 5-Hydroxymethyl-, 5-Formyl- and 5-Carboxydeoxycytidines as Oxidative Lesions and Epigenetic Marks.
Schelter F; Kirchner A; Traube FR; Müller M; Steglich W; Carell T
Chemistry; 2021 Jun; 27(31):8100-8104. PubMed ID: 33769637
[TBL] [Abstract][Full Text] [Related]
5. The level of active DNA demethylation compounds in leukocytes and urine samples as potential epigenetic biomarkers in breast cancer patients.
Linowiecka K; Guz J; Dziaman T; Urbanowska-Domańska O; Zarakowska E; Szpila A; Szpotan J; Skalska-Bugała A; Mijewski P; Siomek-Górecka A; Różalski R; Gackowski D; Oliński R; Foksiński M
Sci Rep; 2024 Mar; 14(1):6481. PubMed ID: 38499584
[TBL] [Abstract][Full Text] [Related]
6. Modular affinity-labeling of the cytosine demethylation base elements in DNA.
Wang F; Zahid OK; Ghanty U; Kohli RM; Hall AR
Sci Rep; 2020 Nov; 10(1):20253. PubMed ID: 33219273
[TBL] [Abstract][Full Text] [Related]
7. Age-dependent levels of 5-methyl-, 5-hydroxymethyl-, and 5-formylcytosine in human and mouse brain tissues.
Wagner M; Steinbacher J; Kraus TF; Michalakis S; Hackner B; Pfaffeneder T; Perera A; Müller M; Giese A; Kretzschmar HA; Carell T
Angew Chem Int Ed Engl; 2015 Oct; 54(42):12511-4. PubMed ID: 26137924
[TBL] [Abstract][Full Text] [Related]
8. The Role of Different TET Proteins in Cytosine Demethylation Revealed by Mathematical Modeling.
Kurasz K; Rzeszowska-Wolny J; Oliński R; Foksiński M; Fujarewicz K
Epigenomes; 2024 May; 8(2):. PubMed ID: 38804367
[TBL] [Abstract][Full Text] [Related]
9. Parp inhibition prevents ten-eleven translocase enzyme activation and hyperglycemia-induced DNA demethylation.
Dhliwayo N; Sarras MP; Luczkowski E; Mason SM; Intine RV
Diabetes; 2014 Sep; 63(9):3069-76. PubMed ID: 24722243
[TBL] [Abstract][Full Text] [Related]
10. Syntheses of two 5-hydroxymethyl-2'-deoxycytidine phosphoramidites with TBDMS as the 5-hydroxymethyl protecting group and their incorporation into DNA.
Dai Q; Song CX; Pan T; He C
J Org Chem; 2011 May; 76(10):4182-8. PubMed ID: 21462947
[TBL] [Abstract][Full Text] [Related]
11. Intragenomic Decarboxylation of 5-Carboxy-2'-deoxycytidine.
Kamińska E; Korytiaková E; Reichl A; Müller M; Carell T
Angew Chem Int Ed Engl; 2021 Oct; 60(43):23207-23211. PubMed ID: 34432359
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of stable-isotope enriched 5-methylpyrimidines and their use as probes of base reactivity in DNA.
Burdzy A; Noyes KT; Valinluck V; Sowers LC
Nucleic Acids Res; 2002 Sep; 30(18):4068-74. PubMed ID: 12235391
[TBL] [Abstract][Full Text] [Related]
13. Alterations in DNA methylation/demethylation intermediates predict clinical outcome in chronic lymphocytic leukemia.
Bagacean C; Tempescul A; Le Dantec C; Bordron A; Mohr A; Saad H; Olivier V; Zdrenghea M; Cristea V; Cartron PF; Douet-Guilbert N; Berthou C; Renaudineau Y
Oncotarget; 2017 Sep; 8(39):65699-65716. PubMed ID: 29029465
[TBL] [Abstract][Full Text] [Related]
14. Measurement of Postreplicative DNA Metabolism and Damage in the Rodent Brain.
Patel JP; Sowers ML; Herring JL; Theruvathu JA; Emmett MR; Hawkins BE; Zhang K; DeWitt DS; Prough DS; Sowers LC
Chem Res Toxicol; 2015 Dec; 28(12):2352-63. PubMed ID: 26447562
[TBL] [Abstract][Full Text] [Related]
15. Deformylation of 5-Formylcytidine in Different Cell Types.
Korytiaková E; Kamińska E; Müller M; Carell T
Angew Chem Int Ed Engl; 2021 Jul; 60(31):16869-16873. PubMed ID: 34110681
[TBL] [Abstract][Full Text] [Related]
16. [TET proteins and epigenetic modifications in cancers].
Ciesielski P; Jóźwiak P; Krześlak A
Postepy Hig Med Dosw (Online); 2015 Dec; 69():1371-83. PubMed ID: 26671928
[TBL] [Abstract][Full Text] [Related]
17. 5-hydroxymethylation of the EBV genome regulates the latent to lytic switch.
Wille CK; Nawandar DM; Henning AN; Ma S; Oetting KM; Lee D; Lambert P; Johannsen EC; Kenney SC
Proc Natl Acad Sci U S A; 2015 Dec; 112(52):E7257-65. PubMed ID: 26663912
[TBL] [Abstract][Full Text] [Related]
18. Tet2 Catalyzes Stepwise 5-Methylcytosine Oxidation by an Iterative and de novo Mechanism.
Crawford DJ; Liu MY; Nabel CS; Cao XJ; Garcia BA; Kohli RM
J Am Chem Soc; 2016 Jan; 138(3):730-3. PubMed ID: 26734843
[TBL] [Abstract][Full Text] [Related]
19. Loss of 5-hydroxymethylcytosine is linked to gene body hypermethylation in kidney cancer.
Chen K; Zhang J; Guo Z; Ma Q; Xu Z; Zhou Y; Xu Z; Li Z; Liu Y; Ye X; Li X; Yuan B; Ke Y; He C; Zhou L; Liu J; Ci W
Cell Res; 2016 Jan; 26(1):103-18. PubMed ID: 26680004
[TBL] [Abstract][Full Text] [Related]
20. De novo DNA methylation drives 5hmC accumulation in mouse zygotes.
Amouroux R; Nashun B; Shirane K; Nakagawa S; Hill PW; D'Souza Z; Nakayama M; Matsuda M; Turp A; Ndjetehe E; Encheva V; Kudo NR; Koseki H; Sasaki H; Hajkova P
Nat Cell Biol; 2016 Feb; 18(2):225-233. PubMed ID: 26751286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
